Richard Miller
Co-Founder, President, CEO & Chairman of the Board

Welcome, everybody. My name is Richard Miller. I'm the CEO of Corvus Pharmaceuticals, and we're delighted to be conducting this webinar and in-person meeting at the Society of Investigative Dermatology Meeting, where Corvus and its collaborators have 2 papers, 2 posters and the pleasure of having 2 of our speakers, 2 of our presenters speak here today with you. So this is a very exciting time for Corvus. I think you'll see both from some of my introductory remarks and from the speakers that we have here today that Corvus really does have a very special compound that's going to have applications in many, many areas of medicine. And so let me start with our forward-looking statements, and introduce today's speakers in addition to myself.

I'm very happy to have Dr. Albert Chiou here. He's a Clinical Professor of Dermatology and the Director of Clinical Research in the Department of Dermatology at Stanford University Medical Center, along with Albert, Dr. Kavita Sarin. Kavita is a Professor of Dermatology and an expert in precision medicine and genetics also in the Department of Dermatology and also in the Cancer Institute at Stanford.

Now I picked these 2 speakers for a reason. Yes, they're very smart. Yes, they have -- they're very photogenic. But more importantly, they complement each other. That is clinical research together with the science and elucidation of mechanisms, which is going to hold for us the promise of new applications and better ways to use our drugs and understand them better. So these 2